Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats

Abstract Objective. This study investigated the effects of short-term intermittent hypoxia (IH) preconditioning on cardiac structure and function in rats and the influence of ischemia reperfusion (I/R) injury. Special attention was then paid to the involvement of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF). Methods. Wistar rats were given IH treatment for 1, 7, 14, or 28 days. Some of them were thereafter subject to myocardial infarction surgery. Right ventricle systolic pressure (RVSP), myocardial capillary density (CD), and mRNA/protein expression of HIF-1α, VEGF, and Bcl-2 in rat myocardial tissue were determined. Apoptotic cell number was determined by TUNEL staining, and concentrations of malondialdehyde (MDA) and superoxide dismutase (SOD) were measured. Results. IH treatment for 1, 7, 14, and 28 days reduced the myocardial infarction size, whereas IH for 28 days increased the RVSP, ratio of right to left ventricle weight (RV/LV+S), and CD. IH up-regulated the mRNA and protein levels of HIF-1α, VEGF, and Bcl-2 both under normal and I/R conditions. The induced expression of HIF-1α and VEGF by IH reached a peak after 7 days of treatment. Moreover, IH for 28 days induced cardiomyocyte apoptosis, whereas prior treatment with IH for 1, 7, 14, and 28 days all markedly attenuated the apoptosis effected by the subsequent I/R injury. IH also decreased the concentrations of MDA but increased those of SOD in myocardial tissue of both in normal rats and following I/R. Conclusions. The present study demonstrates that short-term IH protects the heart from I/R injury through inhibiting apoptosis and oxidative stress. The up-regulation of HIF-1α and VEGF by short-term IH may participate in the cardioprotective effect of IH.

[1]  Liang-Yi Si,et al.  Obstructive sleep apnea syndrome (OSAS) and hypertension: Pathogenic mechanisms and possible therapeutic approaches , 2012, Upsala journal of medical sciences.

[2]  A. Coran,et al.  Dietary L-arginine supplementation reduces Methotrexate-induced intestinal mucosal injury in rat , 2012, BMC Gastroenterology.

[3]  J. Park,et al.  Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation , 2012, International journal of nanomedicine.

[4]  B. Viollet,et al.  Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1‐dependent adenosine monophosphate–activated kinase pathway , 2011, Annals of neurology.

[5]  K. Pritchard,et al.  The protective role of intestinal alkaline phosphatase in necrotizing enterocolitis. , 2010, The Journal of surgical research.

[6]  H. Scharfman,et al.  Protective role of aquaporin‐4 water channels after contusion spinal cord injury , 2010, Annals of neurology.

[7]  A. Ivanina,et al.  Effects of cadmium exposure and intermittent anoxia on nitric oxide metabolism in eastern oysters, Crassostrea virginica , 2010, Journal of Experimental Biology.

[8]  S. Powell,et al.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning. , 2010, Cardiovascular research.

[9]  F. Holsboer,et al.  Depletion of the neural precursor cell pool by glucocorticoids , 2010, Annals of neurology.

[10]  C. Chien,et al.  Repetitive Hypoxic Preconditioning Attenuates Renal Ischemia/Reperfusion Induced Oxidative Injury via Upregulating HIF-1&agr;–Dependent bcl-2 Signaling , 2009, Transplantation.

[11]  M. Derrick,et al.  Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brain , 2009, Annals of neurology.

[12]  D. Lefer,et al.  Protective ischaemia in patients: preconditioning and postconditioning. , 2009, Cardiovascular research.

[13]  N. Barbaro,et al.  Soluble endoglin modulates aberrant cerebral vascular remodeling , 2009, Annals of neurology.

[14]  Gabriel G. Haddad,et al.  Distinct Mechanisms Underlying Tolerance to Intermittent and Constant Hypoxia in Drosophila melanogaster , 2009, PloS one.

[15]  P. Lévy,et al.  Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. , 2009, Journal of the American College of Cardiology.

[16]  J. Simpkins,et al.  Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats. , 2008, Journal of applied physiology.

[17]  Michael L. Smith,et al.  Intermittent Hypoxia: Cause of or Therapy for Systemic Hypertension? , 2008, Experimental biology and medicine.

[18]  P. Schumacker,et al.  Role of hypoxia-inducible factor in cell survival during myocardial ischemia–reperfusion , 2008, Cell Death and Differentiation.

[19]  S. Bertuglia Intermittent hypoxia modulates nitric oxide-dependent vasodilation and capillary perfusion during ischemia-reperfusion-induced damage. , 2008, American journal of physiology. Heart and circulatory physiology.

[20]  B. Buchholz,et al.  HIF activation protects from acute kidney injury. , 2008, Journal of the American Society of Nephrology : JASN.

[21]  B. Walker,et al.  Eucapnic intermittent hypoxia augments endothelin-1 vasoconstriction in rats: role of PKCdelta. , 2008, American journal of physiology. Heart and circulatory physiology.

[22]  David T. Shima,et al.  Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. , 2007, The American journal of pathology.

[23]  P. Clavien,et al.  Improving outcome in patients undergoing liver surgery , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[24]  Max Costa,et al.  Hypoxia-Inducible Factor-1 (HIF-1) , 2006, Molecular Pharmacology.

[25]  Myoung-Gwi Ryou,et al.  β1-Adrenergic receptor antagonism abrogates cardioprotective effects of intermittent hypoxia , 2006, Basic Research in Cardiology.

[26]  E. Manukhina,et al.  Role of Nitric Oxide in Cardiovascular Adaptation to Intermittent Hypoxia , 2006, Experimental biology and medicine.

[27]  M. Cacchio,et al.  HIF‐1α cytoplasmic accumulation is associated with cell death in old rat cerebral cortex exposed to intermittent hypoxia , 2005, Aging cell.

[28]  P. Lévy,et al.  Chronic intermittent hypoxia increases infarction in the isolated rat heart. , 2005, Journal of applied physiology.

[29]  K. Alitalo,et al.  The biology of vascular endothelial growth factors. , 2005, Cardiovascular research.

[30]  H. Ding,et al.  Intermittent hypoxia protects the rat heart against ischemia/reperfusion injury by activating protein kinase C. , 2004, Life sciences.

[31]  D. Ansley,et al.  Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. , 2003, The Journal of thoracic and cardiovascular surgery.

[32]  H. Ding,et al.  ATP-dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury. , 2003, Life sciences.

[33]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[34]  L. Ho,et al.  Neuroprotective Effect of Intermittent Hypoxia on Iron-Induced Oxidative Injury in Rat Brain , 2002, Experimental Neurology.

[35]  Y. Taniyama,et al.  Angiogenesis and Antifibrotic Action by Hepatocyte Growth Factor in Cardiomyopathy , 2002, Hypertension.

[36]  Y. Taniyama,et al.  Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease , 2001, Gene Therapy.

[37]  G. Semenza,et al.  Role of hypoxia‐inducible factor‐1 in hypoxia‐induced ischemic tolerance in neonatal rat brain , 2000, Annals of neurology.

[38]  G Baumgarten,et al.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Semenza HIF-1: mediator of physiological and pathophysiological responses to hypoxia. , 2000, Journal of applied physiology.

[40]  J. Piiper,et al.  Effect of chronic hypoxia on hemodynamics, organ blood flow and O2 supply in rats. , 1993, Respiration physiology.

[41]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[42]  C. Balke,et al.  Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. , 2008, Journal of applied physiology.

[43]  O. Novakova,et al.  Role of oxidative stress in PKC-δ upregulation and cardioprotection induced by chronic intermittent hypoxia , 2007 .

[44]  S. Scharf,et al.  Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. , 1999, Journal of applied physiology.

[45]  M. Fishbein,et al.  Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. , 1978, The American journal of pathology.

[46]  Judith A. Neubauer highlighted topics Physiological and Genomic Consequences of Intermittent Hypoxia Invited Review: Physiological and pathophysiological responses to intermittent hypoxia , 2022 .

[47]  K. Fagan,et al.  highlighted topics Physiological and Genomic Consequencesof Intermittent Hypoxia Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxia , 2001 .